Evidence map›Paper›PMID 38816530›Full record

ArticleNature neuroscience2024

Nf1 mutation disrupts activity-dependent oligodendroglial plasticity and motor learning in mice.

Yuan Pan, Jared D Hysinger, Belgin Yalçın, James J Lennon, Youkyeong Gloria Byun, Preethi Raghavan, Nicole F Schindler, Corina Anastasaki, Jit Chatterjee, Lijun Ni and 11 more

Abstract read
In one paragraph

Article in Nature neuroscience, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. A computational roadmap to activity-dependent myelination.Frontiers in computational neuroscience · 2026
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Yuan Pan *Department of Neurology and Neurological Sciences, Stanford University, Stanford, CA, USA. ypan4@mdanderson.org.ORCID http://orcid.org/0000-0002-9465-8289
Jared D Hysinger *Department of Neurology and Neurological Sciences, Stanford University, Stanford, CA, USA.
Belgin Yalçın *Department of Neurology and Neurological Sciences, Stanford University, Stanford, CA, USA.ORCID http://orcid.org/0000-0001-9689-9062
James J Lennon *Department of Neurology and Neurological Sciences, Stanford University, Stanford, CA, USA.
Youkyeong Gloria ByunDepartment of Neurology and Neurological Sciences, Stanford University, Stanford, CA, USA.
Preethi RaghavanDepartment of Neurology and Neurological Sciences, Stanford University, Stanford, CA, USA.
Nicole F SchindlerDepartment of Neurology and Neurological Sciences, Stanford University, Stanford, CA, USA.
Corina AnastasakiDepartment of Neurology, Washington University School of Medicine, St. Louis, MO, USA.
Jit ChatterjeeDepartment of Neurology, Washington University School of Medicine, St. Louis, MO, USA.
Lijun NiDepartment of Neurology and Neurological Sciences, Stanford University, Stanford, CA, USA.
Haojun XuDepartment of Neurology and Neurological Sciences, Stanford University, Stanford, CA, USA.
Karen MalaconDepartment of Neurology and Neurological Sciences, Stanford University, Stanford, CA, USA.
Samin M JahanDepartment of Neurology and Neurological Sciences, Stanford University, Stanford, CA, USA.
Alexis E IvecDepartment of Neurology and Neurological Sciences, Stanford University, Stanford, CA, USA.
Benjamin E AghoghovwiaDepartment of Symptom Research, University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID http://orcid.org/0000-0001-5630-1361
Christopher W MountDepartment of Neurology and Neurological Sciences, Stanford University, Stanford, CA, USA.
Surya NagarajaDepartment of Neurology and Neurological Sciences, Stanford University, Stanford, CA, USA.
Suzanne ScheafferDepartment of Neurology, Washington University School of Medicine, St. Louis, MO, USA.
Laura D AttardiDepartment of Radiation Oncology, Stanford University, Stanford, CA, USA.
David H GutmannDepartment of Neurology, Washington University School of Medicine, St. Louis, MO, USA. gutmannd@wustl.edu.ORCID http://orcid.org/0000-0002-3127-5045
Michelle MonjeDepartment of Neurology and Neurological Sciences, Stanford University, Stanford, CA, USA. mmonje@stanford.edu.ORCID http://orcid.org/0000-0002-3547-237X

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM007365 · NIGMS · STANFORD UNIVERSITY · PI CHUA, KATRIN F · 1985 to 2021
$33.8M
Medical Scientist Training ProgramT32GM145402 · NIGMS · STANFORD UNIVERSITY · PI Katrin F. Chua · 2022 to 2026
$10.0M
eDyNAmiC - STANFORDOT2CA278688 · NCI · STANFORD UNIVERSITY · PI PAUL S MISCHEL · 2022 to 2026
$7.7M
Studies on oncoprotein-induced feedback: Basic and therapeutic implicationsR35CA210085 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI ROSEN, NEAL · 2016 to 2022
$7.3M
Glioma Circuitry: Bridging Systems Neuroscience and CancerDP1NS111132 · NINDS · STANFORD UNIVERSITY · PI MONJE-DEISSEROTH, MICHELLE · 2018 to 2022
$5.7M
Neuronal Regulation of Low-Grade GliomagenesisR01CA258384 · NCI · STANFORD UNIVERSITY · PI David H Gutmann, Michelle Monje-Deisseroth · 2022 to 2026
$3.1M
Neuronal activity-regulated mechanisms of glioma growthR01NS092597 · NINDS · STANFORD UNIVERSITY · PI MONJE-DEISSEROTH, MICHELLE · 2016 to 2021
$2.1M
Developing Human Induced Pluripotent Stem Cell Precision Oncology ModelsR50CA233164 · NCI · WASHINGTON UNIVERSITY · PI Corina Anastasaki · 2018 to 2026
$1.2M
Ultra high throughput sequencer for sustaining and enhancing multi-scale genomic studiesS10OD025212 · OD · STANFORD UNIVERSITY · PI SNYDER, MICHAEL P. · 2018 to 2018
$600k
Computer ClusterS10OD021763 · OD · STANFORD UNIVERSITY · PI JI, HANLEE P · 2016 to 2016
$481k
Cancer Prevention and Research Institute of Texas (Cancer Prevention Research Institute of Texas) RR210085NCI NIH HHS OT2 CA278688NCI NIH HHS R01 CA258384NCI NIH HHS R50 CA233164NIGMS NIH HHS T32 GM007365NIGMS NIH HHS T32 GM145402NIH HHS S10 OD021763NIH HHS S10 OD025212NINDS NIH HHS DP1 NS111132NINDS NIH HHS R01 NS092597U.S. Department of Defense (United States Department of Defense) W81XWH-15-1-0131U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI) R01CA258384U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NINDS) R35NS07211U.S. Department of Health & Human Services | NIH | NIH Office of the Director (OD) DP1NS111132
6 · The paper itself

Abstract

Neurogenetic disorders, such as neurofibromatosis type 1 (NF1), can cause cognitive and motor impairments, traditionally attributed to intrinsic neuronal defects such as disruption of synaptic function. Activity-regulated oligodendroglial plasticity also contributes to cognitive and motor functions by tuning neural circuit dynamics. However, the relevance of oligodendroglial plasticity to neurological dysfunction in NF1 is unclear. Here we explore the contribution of oligodendrocyte progenitor cells (OPCs) to pathological features of the NF1 syndrome in mice. Both male and female littermates (4-24 weeks of age) were used equally in this study. We demonstrate that mice with global or OPC-specific Nf1 heterozygosity exhibit defects in activity-dependent oligodendrogenesis and harbor focal OPC hyperdensities with disrupted homeostatic OPC territorial boundaries. These OPC hyperdensities develop in a cell-intrinsic Nf1 mutation-specific manner due to differential PI3K/AKT activation. OPC-specific Nf1 loss impairs oligodendroglial differentiation and abrogates the normal oligodendroglial response to neuronal activity, leading to impaired motor learning performance. Collectively, these findings show that Nf1 mutation delays oligodendroglial development and disrupts activity-dependent OPC function essential for normal motor learning in mice.

Indexed as

LearningNeurofibromin 1Neuronal PlasticityOligodendrogliaAnimalsCell DifferentiationFemaleMaleMiceMice, Inbred C57BLMice, TransgenicMotor ActivityMutationNeurofibromin 1Nf1 protein, mouse

Identifiers

PMID38816530
PMCPMC11303248

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.